Jpn. J. Infect. Dis., 59 (2), 129-131, 2006

To see a printable version of the article in the Adobe file format, click this [PDF] link.

Short Communication

Trichosporon asahii Fungemia in a Patient with Non-Hematological Malignancy

Oguz Karabay*, Miguel G. Madariaga1, Esra Kocoglu2, Nevin Ince and Engin Kandirali3

Department of Clinical Microbiology and Infectious Diseases, 2Department of Microbiology and Clinical Microbiology and 3Department of Urology, Izzet Baysal University, Faculty of Medicine, Bolu 14280, Turkey, and 1Section of Infectious Diseases, University of Nebraska Medical Center, Nebraska 68198, USA

(Received November 4, 2005. Accepted February 13, 2006)


*Corresponding author: Mailing address: Department of Clinical Microbiology and Infectious Diseases, Izzet Baysal University, Faculty of Medicine, Bolu 14280, Turkey. Tel: +90-374-2534656, Fax: +90-374-2534615, E-mail: drkarabay@yahoo.com


SUMMARY: Trichosporon fungemia is usually seen in neutropenic patients with underlying hematological malignancies. In this report we describe a fatal case of Trichosporon asahii fungemia in a non-neutropenic patient with a non-hematological malignancy. For 1 week the patient exhibited hematuria, weakness, easy fatigability and headaches. At admission she had anemia, renal failure and evidence of right hydronephrosis and bladder wall masses as detected by CT scan. She did not have a history of tobacco abuse, contact with urinary carcinogens or Schistosoma infestation; her clinical picture was suggestive of bladder cancer. After some investigations the patient underwent radical cystectomy and ileal conduit surgery because of transitional cell carcinoma in the urinary bladder. After an initial uneventful improvement postoperatively the patient deteriorated and died of septic shock despite all reanimation efforts and antibiotherapy including fluconazole. The blood culture obtained 4 days before the patient died revealed T. asahii, which was isolated on the day she died and found to be resistant to fluconazole and caspofungin. This report suggests that clinicians remain aware that T. asahii fungemia may develop in clinically deteriorated patients even if they do not have a hematological malignancy.


Go to JJID Homepage

Go to JJID 59 (2) Contents